At the end of September, the 2027 Lask Award was announced.

Indisputable, Tian Lu won the Lask Award again with his great achievements in the field of epilepsy! However, unlike the last Basic Medicine Prize, Tian Lu won the Clinical Medicine Prize this time, which is very different.

Of course, this time it is exclusive!

Naturally, Tian Lu's winning of the award again set off another trend in China, and the most lively one was the speculation that Tian Lu won the Nobel Prize again.

This time, it’s not blindly optimistic, it’s because everyone has a lot of reasons!

If you only rely on Tian Lu's achievements in epilepsy surgery or epilepsy drug treatment, it is indeed difficult to win the Nobel Prize, because after all, he has already won it once before, and it is not easy to award it to him for the second time so early. But don't forget that in addition to his clinical achievements in epilepsy, Tian Lu's more important contribution is its pathogenesis, clinical grading, diagnosis and treatment standards, etc.!

For more than 20 years, scientific research institutions under Tian Lu have never stopped exploring epilepsy!

Until now, the Institute of Neurobiology is still tirelessly exploring the biochemical characteristics of epilepsy. In the future, organisms are also developing better drugs to treat epilepsy. Neurosurgery has gone further in epilepsy surgical treatment, and surgery and neural stem cell treatment have almost become a conventional method!

Just in 2025, after several years of evaluation and determination, the World Epilepsy Alliance referred to the books "Epilepsy" and "Epilepsy Surgery" written by Tian Lu, and formulated a brand new guide to diagnosis and treatment of epilepsy! It was also at the World Epilepsy Conference this year. After Tian Lu politely rejected the position of chairman, the World Epilepsy Alliance passed the title of honorary chairman unanimously!

Such a huge achievement is enough to win anyone's Nobel Prize!

The results of the Lask Clinical Medicine Prize undoubtedly add a heavy weight to this possibility! So, both at home and abroad, many people are enthusiastically discussing a topic that has not appeared in the past century: Is it possible for a person to win the second Nobel Prize in his lifetime?

This undoubtedly pushed Tian Lu's reputation to another peak.

Although he was quite moved by going to the United States again, Tian Lu really wanted to meet his old friends again, but after considering various factors, he decided to give up this plan. For this reason, Tian Lu specially called Dr. Morpheus from San Francisco Medical Center and asked him to help him receive the award on his behalf. He also expressed his apology at the award ceremony.

There are a lot of things in China, and Tian Lu really doesn't want to go out for half a month just because of receiving an award.

As for looking for more partners, or attracting more international students to return to China and other work, now there is no need for Tian Lu to take action personally. Qian Lele, who has to go out two or three times a year, will naturally take on such tasks, including those research team leaders who are already very prestigious in their respective fields...

During the National Day holiday, just like last year, Tian Lu played happily with his twin children who had already entered the sixth grade of elementary school for several days.

The children are getting older day by day, and their dependence on their parents is decreasing day by day. Tian Lu and Ye Lan also want to take advantage of their willingness to go out with their parents and try their best to accompany them. Otherwise, after this year, they have their own ideas, their ability to be independent, and even their boyfriends and girlfriends, they may not be willing to accompany them even if they beg them!

Speaking of which, Tian Lu still feels that he and Ye Lan are doing quite well in the growth of Tian Huan and Tian Le.

All along, both children have grown up healthily under the care of everyone, both physically and mentally. Moreover, under the education of everyone, the status and wealth of their parents have not caused any adverse effects on them. They are all very kind children. In order to allow their children to grow mentally healthy, Tian Lu and Ye Lan did their best to get them to attend a relatively ordinary school. This is the plan for them to go to junior high school in the future.

If you have to say something that makes Ye Lan a little disappointed, it is that no child can inherit the geniuses of Tianlu, and they seem mediocre in all aspects. Tianlu is quite dissatisfied with this. A saying that often lingers on his lips is that a genius like me is just busy all his life, and it’s better to be an ordinary person and be healthy...

......

As soon as the National Day was over, another good news about Kyoto's medicine came!

"We have obtained the official approval from FDA!"

Meng Yun's voice was full of excitement and excitement, and he shouted loudly on the phone with a slight trembling: "Anti-depressant drugs have been approved for sale in the United States! With this approval, I believe that by the end of the year, our new drugs will be available in various markets around the world without any obstacles!"

FDA's strict review of new drugs is well-known all over the world. All the people who can win the US market usually means they can be passed around the world without any obstacles!

"very good!"

Tian Lu was also happy and said with a smile: "This is called good things going on for a long time. The original plan to go public in July was delayed until October, but for Kyoto Pharmaceutical, which has just entered the international market, the listing is also a huge improvement now! Meng Yun, how about hemostatic gel? Can the plan to go public by the end of the year be successfully implemented?"

"Of course there is no problem!"

Meng Yun said loudly with a very affirmative tone: "We have already greeted Nofi. Once both parties have approved the documents, we will choose to go public at the same time one day and try to expand our influence as much as possible! Don't worry, Kyoto Pharmaceutical's hemostatic gel is only available in the domestic civil market, and of course there is no resistance!"

"good!"

He nodded with satisfaction and Tian Lu smiled and said, "Then your task is to fully market new drugs. In this regard, I will form a team to conduct a global, large-sample-sized clinical depression drug treatment cooperative research. It will take two to three years to show the excellent performance of our new drugs! Of course, in order to achieve this, I am afraid that Kyoto Pharmaceutical will need to provide a large amount of funds, at least 100 million US dollars a year. Is it okay?"

"No problem! It's absolutely fine!"

After hearing what Tian Lu said, Meng Yun's tone changed and he nodded desperately.

How the sales of a new drug after it is launched is ultimately in the hands of those clinicians. But which drug clinicians choose depends on whether the company's marketing channels are unobstructed and whether the new drug can be passed on to the doctors. The second is to see how the performance of the new drug is. Whether it is sufficiently convincing! Otherwise, there are more than a dozen antidepressant drugs on the market now, so why should people choose Kyoto Pharmaceutical?

At this time, we can only rely on data to speak!

Although the number of phase 3 clinical trials before the market was launched was quite large, the scale was still relatively small and the persuasiveness was weaker. A type of disease like depression, which has a large number of patients, must be studied with a large sample size, and it must be led by truly prestigious physicians. The data from large-scale cooperative research organized is convincing!

In this regard, Tian Lu is obviously the most suitable candidate!

Not to mention that this drug was developed in the future, in the field of depression, future biology, including Tianlu, has published a lot of papers in recent years. In addition, Tianlu’s own reputation is really suitable!

And more importantly, it is probably only Tian Lu in China that can organize large-scale global cooperation!

If it is just domestic cooperative research, Kyoto Pharmaceuticals is of course capable of organizing it on its own, but in that case, it will not be very convincing in developed countries such as Europe, America and Japan. They generally only trust their own domestic research data, which is why it is extremely difficult for domestic new drugs to enter those markets.

And if China has a truly global influence in this field, then of course it is Tian Lu...

......

The antidepressant drugs in October and the hemostatic gel in December. Within three months, the launch of a new chemical drug and a new medical consumable in Kyoto Pharmaceutical Group Corporation has undoubtedly injected a cardiac enhancement into the long-standing weak Chinese pharmaceutical market!

These two things are truly heavy-weight patents with extremely high value!

Although domestic drug research and development has improved slightly in the past decade, and new patented drugs are on the market almost every year, there has never been such a heavyweight new drug!

At the end of October, Great Wall Pharmaceutical Group's smoking cessation drugs and detoxification drugs were also launched at the same time!

It is obvious that Great Wall Pharmaceutical Group deliberately put two new drugs on the market together. For this reason, they even delayed the application for the later marketing of smoking cessation drugs, waiting for the process of drug rehabilitation drugs. In the premise of clearly lacking sufficient strength and lacking influence, they hope to use this strong impact to increase the influence of the two new drugs!

But it turns out that their ideas make sense.

In the current drug market, drugs for smoking cessation and drug rehabilitation lack sufficient representations and are in a state of hunger. Needless to say, the performance of the two new drugs of Great Wall Pharmaceuticals is, coupled with the future bio-produced names, it is easy to open up the situation in China first!

There is a need for drug rehabilitation in China, but the market for quitting smoking is much larger. As for foreign countries, the demand for drugs for quitting smoking may not be urgent, but for drug rehabilitation...

Wow, the market will be even bigger!

Everyone can imagine that with these two new drugs alone, Great Wall Pharmaceutical may not have to worry about the next decade!

One by one, good news made Tian Lu feel good. In this continuous pleasure, time passed quietly, and soon passed the last day of 2027...

.............

I was dizzy, and I fell asleep again by typing.

I have been lacking energy recently, so I have to go to bed early and have a good rest tomorrow.
Chapter completed!